Information  X 
Enter a valid email address

Oilex Ltd (OEX)

  Print      Mail a friend       Annual reports

Tuesday 04 September, 2018

Oilex Ltd

Resumption of Trading

RNS Number : 7328Z
Oilex Ltd
04 September 2018
 

ASX Announcement

 

 

4 September 2018

 

ASX: OEX

AIM: OEX

 

High Court of Gujarat Adjournment

Resumption of Trading

 

Further to the announcements made earlier today in relation to Oilex Ltd (Oilex or the Company) appearing in the High Court of Gujarat, India (Court), the Company announces that following today's submissions to the Court, the matter has been adjourned until 19th September 2018 when there will be a further hearing.  The matter has been adjourned at the request of Gujarat State Petroleum Corporation to consider the reply filed by Oilex ahead of what is anticipated to be the final hearing. Further announcements will be made in due course. 

 

As a result of this announcement, trading in Oilex's shares on Aim will resume immediately.

 

 

 

 

For and on behalf of Oilex Ltd

 

 

 

 

Joe Salomon

Managing Director

 

For further information, please contact:

Investor Enquiries

Oilex Ltd

Joe Salomon

Managing Director

Email: [email protected]

Tel: +61 8 9485 3200

Australia

AIM Broker

Cornhill Capital Limited

Broker

Daniel Gee

Email: [email protected]

 

Tel: +44 20 3700 2500

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer   

Email: [email protected]

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: [email protected]

[email protected]

Tel:+ 44 20 7390 0230

UK

Media Enquiries (Aus)

Citadel-MAGNUS

Michael Weir

Email: [email protected]

Tel: +618 6160 4900

Australia

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCLIMBTMBTMBRP

a d v e r t i s e m e n t